Showing results (81-90 of 187) with videos related to

Sort By:
Pageof 19
International Journal of Clinical Oncology|October 27, 2009
Current therapeutic strategies for anal squamous cell carcinoma in JapanAtsuo Takashima, Yasuhiro Shimada, Tetsuya Hamaguchi, et al.
Anticancer Research|June 30, 2016
Comparison of Panitumumab Plus Irinotecan and Cetuximab Plus Irinotecan for KRAS Wild-type Metastatic Colorectal CancerToshifumi Yamaguchi, Satoru Iwasa, Kengo Nagashima, et al.
BMC Research Notes|April 30, 2014
Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancerNaoki Takahashi, Yasuhide Yamada, Hirokazu Taniguchi, et al.
Cancer Science|December 11, 2008
Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancerYoshinori Hirashima, Yasuhide Yamada, Junichi Matsubara, et al.
Japanese Journal of Clinical Oncology|December 3, 2019
Efficacy of aspirin for stage III colorectal cancer: a randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial)Kenichi Miyamoto, Atsuo Takashima, Junki Mizusawa, et al.
Anticancer Research|February 5, 2020
Risk Factors of Severe Benign Cicatricial Stricture After Definitive Chemoradiation for Localized T3 Esophageal CarcinomaNatsuko Satomi-Tsushita, Yoshitaka Honma, Kengo Nagashima, et al.
Oncology|November 27, 2008
Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancerDaisuke Takahari, Yasuhide Yamada, Natuko T Okita, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 10, 2009
Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestineMakiko Ono, Kuniaki Shirao, Atsuo Takashima, et al.
British Journal of Cancer|August 5, 2023
A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancerTaiki Hashimoto, Daisuke Takayanagi, Junpei Yonemaru, et al.
ESMO Open|June 25, 2019
Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancerMasahiko Aoki, Hirokazu Shoji, Kengo Nagashima, et al.
Pageof 19